Pharmafile Logo
Pharmafocus logo
Advanced Search
merckwindow_web

MSD and Samsung Bioepis terminate development of Lantus biosimilar for diabetes

October 15, 2018
Research and Development, Sales and Marketing Lantus, MSD, Samsung Bioepis, Sanofi, biosimilar, diabetes, pharma

MSD has reportedly terminated a previous agreement with Samsung Bioepis which would have seen them collaborate on a biosimilar version …

News
ai_robot

AI, big data: Making a case for faster drug discovery

October 15, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Big Data, feature, healthcare, research

They’re two of the biggest buzzwords getting professionals excited across pharma – Anjali Shukla explores the ways in which AI …

Feature
5204602349_c87b204860_z

FDA advisory panel approves AcelRx’s opioid pain drug Dsuvia

October 15, 2018
Sales and Marketing FDA, approval, comittee, opioids

An FDA advisory panel voted 10 to 3 to recommend the approval of AcelRx Pharmaceuticals’ opioid pain drug Dsuvia (sufentanil) …

News
emergency-ambulance-london-vehicle-medical-1665303

Digital system may prevent £300m prescription fraud losses for NHS by 2020

October 15, 2018
Sales and Marketing NHS, fraud, government, prescription fraud, uk politics

The British government are launching a new digitised system aimed at cracking down on prescription fraud in the NHS. However …

News

BMS’ Opdivo fails to improve overall survival in small-cell lung cancer

October 15, 2018
Research and Development, Sales and Marketing BMS< Opdivo, Bristol-Myers Squibb, Cancer, lung cancer, pharma

Bristol-Myers Squibb’s Opdivo (nivolumab) failed to deliver on its primary endpoint in a Phase 3 study in small-cell lung cancer, …

News

Health innovation system is broken and failing patients, new report argues

October 15, 2018
Sales and Marketing IP, industry, intellectual property, priofit, research

The pharmaceutical industry is incentivised to set high prices and deliver short-term returns to shareholders, rather than focusing on riskier, …

News
novo_flag

Novo Nordisk’s Fiasp shows strong blood sugar control in under-18 type 1 diabetes patients

October 12, 2018
Medical Communications, Research and Development Fiasp, Novo Nordisk, Type 1 diabetes, diabetes, pharma

New data unveiled by Novo Nordisk has shown that its insulin injection Fiasp (fast-acting insulin aspart) could provide a better …

News
top_10_image

Top Ten most popular articles on Pharmafile.com this week

October 12, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing WHO, biosimilars. GSK, manufacturing, pharma, top 10

Politics played a big role in pharma this week after Trump introduced legislation aimed at reducing the price of drugs. …

News
trvn1

Trevena’s opioid injection fails to win over FDA committee

October 12, 2018
Medical Communications, Sales and Marketing FDA, Trevena, US, oliceridine, opioid, opioid crisis, pharma

Trevena has seen its opioid injection oliceridine fail to win over an FDA advisory panel in the management of acute …

News

Chanelle Pharma announces €86m investment over next five years

October 12, 2018
Medical Communications Ireland, chanelle, generics, investment, research

Chanelle Pharmaceuticals, one of the largest Irish-owned pharmaceutical companies in Ireland, have announced an €86 million investment programme over the …

News

USA struggles and middle income countries could do more in tackling health inequality according to Oxfam report

October 12, 2018
Medical Communications Latin America, USA, health, inequality, oxfam

A cluster of Latin American countries such as Costa Rica, Uruguay and Argentina, and a cluster of OECD countries with …

News

Living with Langerhans Cell Histiocytosis

October 11, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Langerhans Cell Histiocytosis, feature. pharma, patient experience, rare diseae

Affected as a young child by a rare disease which targets just one in 200,000 and led to neurodegeneration throughout …

Feature
roche__tree

Roche’s Ocrevus shows earlier, better outcomes in primary progressive and relapsing MS

October 11, 2018
Research and Development Ocrevus, Roche, multiple sclerosis, pharma

Roche has unveiled new five-year data from three Phase 3 open-label extension studies investigating the efficacy of Ocrevus (ocrelizumab) in …

News
38254130862_0f3fa01db3_z

New US trade policy may limit foreign investment into biotechs

October 11, 2018
Research and Development CIFUS, Trump, america, biotech, capital, foreign investment

The US Trump Administration have issued new rules, which will put foreign investment into companies involved in the development and …

News

Sequiris invest £40m into expansion of Liverpool plant creating 100 new jobs

October 11, 2018
Manufacturing and Production, Research and Development Jobs, Vaccine, investment, liverpool

The Liverpool-based vaccine-maker Sequiris is investing £40 million into the expansion of its operations in the Speke area of Liverpool. …

News
image_readtop_2018_569751_15365546683454581

Celltrion’s Rituxan biosimilar gets unanimous backing from FDA committee

October 11, 2018
Sales and Marketing FDA, Oncologic Drugs Advisory Committee, Rituxan, Roche, Truxima

FDA approval looks to be in reach for Celltrion, as an advisory committee for the US regulator voted unanimously to …

News
29496564944_a9faceb1c2_z

Trump signs trust-busting biosimilar bill into law

October 11, 2018
Business Services, Sales and Marketing FTC, Trump, biosimilars, generics, us politics

President Donald J Trump has signed off a law which requires drugmakers and pharma firms to reveal the details of …

News

Woodley attending Outsourcing in Clinical Trials OCT – Nordics

October 10, 2018
Outsourcing in Clinical Trial, medical and laboratory equipment rental specialists

 

News
Press release

Manage Temperature Monitoring the EZ way with Woodley…

October 10, 2018
Investigational Medicinal Product, Temperature Monitoring, clinical trials

Manage Temperature Monitoring the EZ way with Woodley…As Clinical Trials protocols become ever more complex so too has the need …

Feature
Thought Leadership
psm_v46_d168_mesial_view_of_the_human_brain

Increased funding and research could help address unmet mental health needs

October 10, 2018
Research and Development funding, global data, mental health, research

Unmet needs relating to mental health could be met through increasing funding and research, according to data analytics firm GlobalData. …

News
The Gateway to Local Adoption Series

Latest content

Rare diseases – spinal muscular atrophy

January 30, 2026

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026

Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development US

January 29, 2026